News release:
Friday March 31, 11:52 am Eastern Time
Company Press Release
Mytec Technologies Inc. Announces Support of BioAPI Specification
TORONTO--(BUSINESS WIRE)--March 31, 2000--Mytec Technologies Inc. (TSE:MYT. - news) announces its support of the BioAPI specification yesterday in Washington, D.C. BioAPI is the industry-standard Application Programming Interface for biometric devices, and as such provides a convenient mechanism for including biometrics into applications running on personal computer systems. Mytec has actively participated in the BioAPI development process over the last two years by providing technical contributions in the area of biometric security. Mytec is also a member of the BioAPI Steering Committee, along with Intel, Compaq, Unisys, SAFLINK, Iriscan, and NIST (National Institute of Standards and Technology). The Steering Committee was elected by the member companies (currently forty-seven in number) of the BioAPI Consortium, and its responsibilities include management of the specification development process and administration of the Consortium.
Dennis Hollingshead, President and CEO of Mytec Technologies Inc., said, ``The publication of the BioAPI specification will provide the means for wide-scale deployment of biometric systems. BioAPI will provide assurance to customers that the biometrics industry has come of age; biometric technology has now matured to the point that an industry-standard interface can be defined. This is a very important stage in the development of the market. Mytec is well-positioned to consolidate upon this market potential.'
Dr. Colin Soutar, Director of Research and Development of Mytec Technologies Inc. emphasized that ``the BioAPI specification facilitates the use of biometric devices with a wide range of verification and identification capabilities. All PC-based and self-contained algorithms, whether in stand-alone or client-server mode, are supported by the specification.
``The BioAPI infrastructure also provides support for high-security devices used to biometrically authorize critical transactions. The ability for a cryptographic key to be closely bound to a biometric template is inherent in the BioAPI specification. This will facilitate adoption of algorithms such as Mytec's patented Biometric Encryption algorithm, and will therefore provide a mechanism to integrate Biometric Encryption with a number of different types of biometric images. This will extend the capabilities of Mytec's software algorithm technology.'
About Mytec
Mytec Technologies Inc. specializes in the development of core biometric technologies for licensing to OEM's and customers that require advanced network or physical access security. Mytec's biometric technologies provide an unparalleled blend of convenience and security that extends well beyond the traditional identity methods such as passwords or entry cards, and have the potential to enable secure wireless e-commerce. Mytec's unique Biometric Encryption process links a 128-bit digital key with a biometric image to create a secure package of information known as a Bioscrypt. The Bioscrypt is used to secure information that can only be unlocked by presenting the correct biometric image. Biometric Encryption has been patented for use with all types of biometric images, such as fingerprints, iris, voice and face. Through Counterforce, the company's wholly-owned subsidiary, Mytec also provides alarm monitoring services to more than 700 independent alarm company partners who sell, install and service commercial and residential security alarm systems.Visit the company's web site at www.mytec.com.
Mytec Technologies Inc., the Mytec logo, Bioscrypt and Touchstone are trademarks or registered trademarks of Mytec Technologies Inc. Forward-looking statements in this news release are made pursuant to the ``safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties.
BioAPI is a trademark of the BioAPI consortium. Additional information on BioAPI may be found at www.bioapi.org. |
